Shigeto Miura

3.9k total citations
84 papers, 3.1k citations indexed

About

Shigeto Miura is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Shigeto Miura has authored 84 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Shigeto Miura's work include Cancer Risks and Factors (14 papers), Breast Cancer Treatment Studies (14 papers) and Cancer Treatment and Pharmacology (13 papers). Shigeto Miura is often cited by papers focused on Cancer Risks and Factors (14 papers), Breast Cancer Treatment Studies (14 papers) and Cancer Treatment and Pharmacology (13 papers). Shigeto Miura collaborates with scholars based in Japan, United States and South Korea. Shigeto Miura's co-authors include Yuji Mishina, Kaoru Hirose, Kazuo Sugamura, Kazuo Tajima, Nobuyuki Hamajima, Kazuko Murata, Naoto Ishii, Richard R. Behringer, Hiroji Iwata and Michelle D. Tallquist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Shigeto Miura

83 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeto Miura Japan 31 1.2k 1.1k 495 413 362 84 3.1k
Johannes W.G. Janssen Germany 34 1.9k 1.6× 688 0.6× 577 1.2× 703 1.7× 376 1.0× 87 4.1k
Milena Paglierani Italy 32 1.6k 1.3× 1.1k 1.0× 376 0.8× 724 1.8× 381 1.1× 105 3.7k
K. Czerwenka Austria 41 1.5k 1.2× 1.3k 1.1× 827 1.7× 646 1.6× 567 1.6× 179 4.6k
P Speiser Austria 31 1.3k 1.1× 925 0.8× 224 0.5× 777 1.9× 440 1.2× 163 3.0k
Giuliano Mazzini Italy 30 1.5k 1.2× 662 0.6× 206 0.4× 597 1.4× 224 0.6× 151 3.2k
Mitsuaki Suzuki Japan 41 1.8k 1.5× 1.0k 0.9× 908 1.8× 676 1.6× 292 0.8× 245 5.8k
Patricia J.T.A. Groenen Netherlands 38 2.0k 1.7× 1.0k 0.9× 395 0.8× 376 0.9× 372 1.0× 129 4.3k
Johan Richter Sweden 36 1.5k 1.3× 851 0.7× 773 1.6× 228 0.6× 418 1.2× 145 4.2k
Eric A. Van Marck Belgium 33 1.0k 0.9× 1.2k 1.0× 193 0.4× 791 1.9× 144 0.4× 75 3.5k
John Anderson United Kingdom 36 1.4k 1.2× 1.6k 1.4× 1.1k 2.3× 551 1.3× 505 1.4× 147 4.3k

Countries citing papers authored by Shigeto Miura

Since Specialization
Citations

This map shows the geographic impact of Shigeto Miura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeto Miura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeto Miura more than expected).

Fields of papers citing papers by Shigeto Miura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeto Miura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeto Miura. The network helps show where Shigeto Miura may publish in the future.

Co-authorship network of co-authors of Shigeto Miura

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeto Miura. A scholar is included among the top collaborators of Shigeto Miura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeto Miura. Shigeto Miura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kimura, Morihiko, Takeshi Tominaga, Yuichi Takatsuka, et al.. (2009). Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan. Breast Cancer. 17(3). 190–198. 5 indexed citations
3.
Takahashi, Minoru, Daisuke Iwaki, Kazuko Kanno, et al.. (2008). Mannose-Binding Lectin (MBL)-Associated Serine Protease (MASP)-1 Contributes to Activation of the Lectin Complement Pathway. The Journal of Immunology. 180(9). 6132–6138. 126 indexed citations
4.
Qi, Xiaoxia, Jing Hao, Jie Hu, et al.. (2004). BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proceedings of the National Academy of Sciences. 101(16). 6027–6032. 333 indexed citations
5.
Tominaga, Takeshi, Hiroki Koyama, Tetsuya Toge, et al.. (2003). Randomized Controlled Trial Comparing Oral Doxifluridine Plus Oral Cyclophosphamide With Doxifluridine Alone in Women With Node-Positive Breast Cancer After Primary Surgery. Journal of Clinical Oncology. 21(6). 991–998. 16 indexed citations
6.
Hirose, Kaoru, Nobuyuki Hamajima, Toshiro Takezaki, Shigeto Miura, & Kazuo Tajima. (2003). Physical exercise reduces risk of breast cancer in Japanese women. Cancer Science. 94(2). 193–199. 32 indexed citations
7.
Hirose, Kaoru, Toshiro Takezaki, Nobuyuki Hamajima, Shigeto Miura, & Kazuo Tajima. (2003). Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women. International Journal of Cancer. 107(2). 276–282. 79 indexed citations
8.
Miura, Shigeto & Yuji Mishina. (2003). Whole‐embryo culture of E5.5 mouse embryos: Development to the gastrulation stage. genesis. 37(1). 38–43. 10 indexed citations
9.
Iwase, Takuji, et al.. (2002). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 11(2). 155–160. 3 indexed citations
10.
Mishina, Yuji, Mark C. Hanks, Shigeto Miura, Michelle D. Tallquist, & Richard R. Behringer. (2002). Generation ofBmpr/Alk3conditional knockout mice. genesis. 32(2). 69–72. 232 indexed citations
11.
Inoue, Manami, Kazuo Tajima, Mitsuhiro Mizutani, et al.. (2001). Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Letters. 167(2). 175–182. 137 indexed citations
12.
Hirose, Kaoru, Kazuo Tajima, Nobuyuki Hamajima, et al.. (2001). Association of Family History and Other risk factors with Breast Cancer Risk among Japanese Premenopausal and Postmenopausal Women. Cancer Causes & Control. 12(4). 349–358. 43 indexed citations
13.
Hamajima, Nobuyuki, Hiroji Iwata, Yuichi Obata, et al.. (2000). No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan. Japanese Journal of Cancer Research. 91(9). 880–885. 32 indexed citations
14.
Hirose, Kaoru, Kazuo Tajima, Nobuyuki Hamajima, et al.. (1999). Effect of body size on breast-cancer risk among Japanese women. International Journal of Cancer. 80(3). 349–355. 50 indexed citations
15.
Koyama, Hiroki, Takeshi Tominaga, Kazuaki Asaishi, et al.. (1999). A Randomized Controlled Comparative Study of Oral Medroxyprogesterone Acetate 1,200 and 600 mg in Patients with Advanced or Recurrent Breast Cancer. Oncology. 56(4). 283–290. 4 indexed citations
16.
Miura, Shigeto & Hiroki Koyama. (1998). Results of Questionnaires Concerning Breast Cancer Surgery in Japan: An Update in 1998. Breast Cancer. 5(3). 209. 4 indexed citations
17.
Hamajima, Nobuyuki, et al.. (1998). Survey on pamphlet use explaining breast cancer operations in Japan. Breast Cancer. 5(3). 235–241. 2 indexed citations
18.
Miura, Shigeto, et al.. (1996). Magnetic Field Effects on the Electrochemical Potential(Research in High Magnetic Fields). Science Reports of the Research Institutes, Tohoku University, Series A: Physics, Chemistry, and Metallurgy. 42(2). 309–313. 1 indexed citations
19.
20.
Nakagawa, Yasuaki, et al.. (1981). Design, Construction and Test of a Small Bitter Magnet usable for a Hybrid Magnet. Science Reports of the Research Institutes, Tohoku University, Series A: Physics, Chemistry, and Metallurgy. 30(30). 86–97. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes W.G. Janssen Breakdown of academic impact, for papers by Milena Paglierani Breakdown of academic impact, for papers by K. Czerwenka Breakdown of academic impact, for papers by P Speiser Breakdown of academic impact, for papers by Giuliano Mazzini Breakdown of academic impact, for papers by Mitsuaki Suzuki Breakdown of academic impact, for papers by Patricia J.T.A. Groenen Breakdown of academic impact, for papers by Johan Richter Breakdown of academic impact, for papers by Eric A. Van Marck Breakdown of academic impact, for papers by John Anderson
Rankless by CCL
2026